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Abstract 
There is compelling evidence in the literature to support the application of Raman spectroscopy 
for analysis of bodily fluids in their native liquid state. Naturally, the strategies described in 
the literature for Raman spectroscopic analysis of liquid samples have advantages and 
disadvantages. Herein, recent advances in the analysis of plasma/serum in the liquid state are 
reviewed. The potential advantages of Raman analysis in the liquid form over the commonly 
employed infrared absorption analysis in the dried droplet form are initially highlighted. 
Improvements in measurement protocols based on inverted microscopic geometries, clinically 
adaptable substrates, data preprocessing and analysis, and applications for routine monitoring 
of patient health as well as therapeutic administration are reviewed. These advances suggest 
that clinical translation of Raman spectroscopy for rapid biochemical analysis can be a reality. 
In the future, this method will prove to be highly beneficial to clinicians for rapid screening 
and monitoring of analytes and drugs in the biological fluids, and to the patients themselves, 
enabling early treatment, before the disease becomes symptomatic, allowing early recovery. 
Keywords: Raman spectroscopy, Extended Multiplicative Signal Correction, Therapeutic drug 
monitoring, Disease diagnosis, Serum, Plasma, Partial Least Squares Regression 
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1. Introduction 
Vibrational spectroscopic techniques, both Raman and Infrared (IR) absorption, have been 
extensively explored over the last two decades for obtaining the biochemical composition of 
bodily fluids in the field of biomedical analysis [1–10]. The sensitivity to detect subtle changes 
in the biochemical composition and ability to detect the presence of specific biomarkers or 
drugs makes vibrational spectroscopy an ideal tool for the early diagnosis of various 
pathologies [11–14] and therapeutic drug monitoring [15–17]. Both techniques are truly label 
free, rapid, cost-effective, easy to operate, non-destructive and provide the unique molecular 
fingerprint of the sample with minimal sample preparation steps. Such techniques are 
particularly attractive for routine analysis of biofluids, as they are easy to apply, require 
minimal sample preparation and are readily adaptable to analysis of various bodily fluids [1-
5], potentially reducing clinical analysis time, and alleviating patient angst (figure 1).  
Over the past decades, there have been numerous studies of analytes in biofluids using 
vibrational spectroscopy, and, in recent years, attenuated total reflection (Fourier Transform) 
IR (ATR-FTIR) has become popular for rapid screening of biofluids, particularly blood plasma 
and serum [13]. Notably, however, ATR-FTIR is predominantly conducted on dried droplets 
of bodily fluids, adding to the complexity of the measurement and the clinical workflow [18, 
19]. In comparison, the prospect of using Raman spectroscopy for the label-free extraction of 
biochemical information from biological fluids is attractive from various perspectives; liquid 
sample analysis, no requirement for additional reagents, ease of use, speed, cost-effectiveness 
and low sample volume requirement. The application of Raman spectroscopy to biomolecules 
and even tissues was first demonstrated as early as the 1960s, and by the mid 1970s biomedical 
applications were explored [20–22]. Whole cell and tissue studies have been carried out on a 
range of pathologies [23–25] and in vivo studies [26, 27] have demonstrated the prospective 
for diagnostic applications. Raman microspectroscopy potentially lends itself naturally to the 
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analysis of liquid biofluids and such applications have attracted considerable attention in recent 
years. There have been, however, multiple strategies that are used to perform such real-time 
analysis and these options must be carefully considered to achieve optimum Raman spectra 
from liquid samples [28, 29]. Several studies have reported the proof-of-concept of liquid 
sample analysis using Raman spectroscopy [30–37]. However, no systematic validation and 
testing of protocols has yet been carried out to consider this technique for real-time clinical 
applications. This review will summarise the recent advances in the standardisation of 
measurement protocol for biological fluid analysis in the liquid state using Raman 
spectroscopy, in terms of the optimal wavelength and substrate, serum fractionation methods, 
data collection, pre-processing and post processing steps to obtain results with higher accuracy 
and sensitivity. Applications for both analysis of imbalances of high and low molecular weight 
serum constituent components of pathological and clinical significance, as well as therapeutic 
drug monitoring will be considered. Note, that the studies considered do not require signal 
enhancement techniques such as surface enhanced Raman spectroscopy, and therefore such 
techniques are not considered within the scope of the review. However, as they has been 
extensively explored in recent times, a brief comparison of the techniques to infrared 
absorption based techniques is provided. 
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Figure 1. Early disease diagnosis, prognosis and treatment is possible with real-time analysis 
of patient serum using the inverted Raman spectral analysis.  
 
2. Raman vs Infrared absorption spectroscopy 
Although Raman and IR spectroscopy are considered complementary techniques, the 
fundamental physical phenomena governing them are very different, and thus result in distinct 
technical challenges to their clinical implementation [6, 38]. As IR spectroscopy is based on 
absorption due to electric dipole transitions associated with molecular vibrations, water cannot 
be used as a solvent, due to its intense absorption in the IR region due to the highly polar OH 
groups [39, 40]. IR analysis of bodily fluids has therefore been predominantly performed on 
air-dried samples, which leads to chemical and physical inhomogeneity due to the so – called 
“coffee ring” effect and thereby inconsistencies in the results obtained [18, 19, 39]. Raman 
spectroscopy is an inelastic scattering technique based on the Raman effect, i.e., the coupling 
Patient serum
Real time analysis
Early disease diagnostics
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of the oscillating electronic polarisabilities of the molecular bond with the source 
electromagnetic field [41, 42]. The distinct advantage of this technique is that it is compatible 
with water-rich samples such as serum/plasma, as water molecules have a relatively low 
scattering cross section and do not mask the scattering from the solutes in the aqueous solutions 
[43–45]. Zhao et al., developed a fast and reliable approach to identify and quantify liquid 
injectables in the liquid state for spurious/falsely-labelled/falsified/counterfeit medical 
products (SFFCs) using Raman spectrophotometer of 785nm excitation source [46]. Principle 
Component Analysis (PCA) combined with Classical Least Squares (CLS) chemometric 
methods were used to overcome the problems of the interference signals of glass containers 
and solutions, and weak signals from active pharmaceutical ingredients were finally extracted. 
Water was used as an internal standard for normalisation and CLS quantitation models were 
established. When Raman predicted values were compared with HPLC reference results, the 
relative error of eight doxofylline liquid injectable samples were within 5% and three low-
concentration Levofloxacin in Levofloxacin Lactate and Sodium Chloride Injection samples 
were within 10%, demonstrating this approach to be a reliable and rapid screening method to 
detect SFFCs in liquid dosage forms. In order to extend this Raman spectroscopic set up for 
the study of biological fluids, further studies should be conducted on biological fluids to extract 
clinically relevant information.  
Multianalyte, dried serum analysis has previously been reported using mid-infrared 
spectroscopy, for the simultaneous quantitation of eight serum analytes: total protein content, 
albumin, triglycerides, cholesterol, glucose, urea, creatinine and uric acid [47] and for 
simultaneous quantification of glucose and urea analytes along with malaria parasitemia 
quantification using ATR-FTIR [11]. As a direct comparison of the techniques of mid-IR and 
Raman spectroscopy, together with multivariate data analysis, for the quantitative analysis of 
serum, Rohleder et al. analysed the serum of 247 blood donors [36]. The IR analysis was 
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undertaken on dried droplets, whereas the Raman analysis was of the liquid serum and/or serum 
filtrates. Under their investigation for the quantification of glucose, urea, uric acid, LDL 
cholesterol, HDL cholesterol, total protein, cholesterol and triglycerides, Raman and mid-
infrared spectroscopy delivered similar accuracies for the prediction of physiologically relevant 
analyte levels [36]. More recently, Parachalil et al., undertook a similar comparison of Raman 
compared to ATR-FTIR, using identical sample preparation and analysis protocols, to 
quantitatively monitor diagnostically relevant changes of glucose [44], indicating that Raman 
spectroscopy in the liquid state can perform at least as well as ATR-FTIR, without the need for 
the drying step.  
Notably, whereas many of the previous studies of liquid serum samples employed an upright 
microscopic geometry, that of Parachalil et al., employed an inverted geometry, as previously 
demonstrated by Bonnier et al. [62]. Improved analysis of serum using Raman spectroscopy 
was reported when the sample was analysed in the inverted geometry using a water immersion 
objective with a 785nm laser and CaF2 substrate. A drop of water is used to minimise the 
differences in the refractive indices between sample, objective and the substrate, and thus 
improve the optical coupling. However, the water drop does not contribute to the data collected, 
as it is outside the focus of the beam. As a much better cost-effective, clinically adaptable 
option, Parachalil et al. introduced a commercial, cover slip (of 0.16-0.19 mm thickness) 
bottomed vesicle (Lab-tek plate) as the substrate. The use of glass precludes the use of a 785nm 
source [48, 49], and thus a 532nm laser was chosen as the source, which provides a strong 
Raman signal of water with minimal background interference (Figure 2). This set-up also has 
the added advantage of providing high quality, consistent Raman spectra from a sample 
volumes as low as 1μL. Medipally et al. also reported the benefits of using inverted Raman 
geometry to analyse plasma samples of small volume (20µL) from prostate cancer patients 
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[50]. Note, enhanced methods such as Surface Enhanced Raman Spectroscopy (SERS) are not 
considered in this review. 
 
Figure 2. Thin glass bottomed Lab-Tek plate combined with inverted Raman analysis can 
collect spectral data from very low amount of samples (1µL) making it an ideal tool for clinical 
laboratory analysis. Spectra can be recorded in less than 1 minute. 
 
3. Measurement of Plasma vs Serum 
Human blood plasma or serum are the most commonly studied bodily fluids for disease 
diagnosis, biomarker discovery and therapeutic drug monitoring [51–57]. While plasma and 
serum are both cell-free fluids obtained from blood samples by centrifugation, they differ on 
the basis of whether clotting has been allowed or not. One question which inevitably arises in 
performing biochemical estimation of blood, therefore, is what is the right choice of medium 
to be used, plasma or serum? Plasma is commonly obtained as the supernatant layer after 
refrigerated centrifugation of blood collected with anticoagulants (such as potassium- 
Ethylenediaminetetraacetic acid, sodium-citrated and lithium-heparin) for 10 minutes at 2,000 
x g to concentrate unwanted cells and platelets [58]. For serum preparation, whole blood is 
allowed to clot at room temperature for about 15–30 minutes, whereupon the clot is removed 
by refrigerated centrifugation at 1,000–2,000 x g for 10 minutes, often separated by a gel 
component to avoid contamination [58]. It is important to immediately transfer the supernatant 
(plasma or serum) into a clean polypropylene tube and maintain samples at 2–8°C while 
handling. If the samples are not analysed immediately, they should be stored at –20°C or 
60x
LUMPlan F1
The volume of the 
sample measured can 
be as low as 1μL. The 
spectral features are 
found to be stable at 
the highest and the 
lowest volume
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preferably lower [59]. The time delay between centrifugation and separation of the globular 
fraction and the improper storage conditions could negatively impact on the protein profile 
obtained [59]. Therefore, standardisation of sample collection, processing and storage 
protocols is crucial to ensure reproducibility and consistency in the results obtained. It is also 
recommended to avoid freeze-thaw cycles, because this may have detrimental effects on many 
serum components [60].  
Blood serum and plasma are predominantly composed of water (~90%), minerals, organic 
substances and gas (oxygen, carbon dioxide) [60]. Proteins are the predominant molecular 
components of blood plasma, the remaining constituents being carbohydrates, lipids and amino 
acids. Serum albumin, globulins, fibrinogen and a handful of other abundant proteins account 
for 99% of total plasma/serum proteins, while the remaining 1% is composed of low abundance 
circulatory proteins [54]. Additionally, plasma or serum contain more than 114,000 known 
metabolites at varying concentration level (<1 nmol/L to mmol/L) [60]’ 
Since most of the clinical analytical instruments are accurate for both serum and plasma, these 
two terms are used erroneously interchangeably in most clinical tests [7]. Notably, many 
studies that have been reported to be carried out in serum were in fact carried out in plasma 
[61–66]. 
Medipally et al. investigated the effect of different instrumental and sample preparation 
parameters to identify a combination that would reduce the overall acquisition time for 
recording spectra from blood plasma with minimal of sample preparation steps [50]. Out of the 
four different laser lines (785 nm, 660 nm, 532 nm and 473 nm) tested, only the 785 nm laser 
line gave a reliable biochemical signature of liquid plasma samples. Fluorescence was observed 
when the 660 nm laser line was used and a resonance Raman effect due to the presence of β 
carotene was observed when 532 and 473 nm laser lines were used. Plasma samples from 10 
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prostate cancer patients and 10 healthy volunteers were used in this study. A 96 well plate 
(cover glass bottomed) was used to hold samples of 20 µL and the Raman spectra were 
recorded in the inverted geometry. Spectral preprocessing steps and principal component 
analysis – linear discriminant analysis (PCA-LDA) was performed in the R environment. The 
classification resulted in a sensitivity and specificity of 96.5% and 95% respectively. Although 
a cost effective approach to perform rapid analysis of liquid plasma is demonstrated in this 
study, no attempts have been made to reduce the effect of spectral interferents while using the 
532 nm laserline.  
In validating the protocols for analysis of bodily fluids using inverted Raman microscopic 
analysis using 532nm, Parachalil et al. utilised a simulated blood plasma mixture of albumin, 
fibrinogen, cytochrome C, and vitamin B12 [44]. The findings from this study with simulated 
plasma protein mixture show that the poorly soluble fibrinogen component obscured the 
systematic variations of the protein concentrations due to high degree of scattering. Mild 
sonication of the aqueous solution helped to improve the solubility of fibrinogen and 
significantly improved the Raman spectral intensity by minimising scattering effects. Since 
centrifugal filtration failed to separate fibrinogen from rest of the proteins, ion exchange 
chromatography had to be applied to separate the fibrinogen by altering its net surface charge. 
Although ion exchange chromatography is a quick method to separate proteins, this method 
has to be tailored for a specific protein depending on its charge and cannot be used as a ’one-
for-all’ separation kit for all the proteins. In terms of the applications of Raman Spectroscopy 
for analysis of blood content, it is therefore recommended that fibrinogen content should be 
extracted from plasma, and mildly sonicated for quantitation, whereas blood serum can be 
readily further analysed for High Molecular Weight Fraction (HMWF) and Low Molecular 
Weight Fraction (LMWF) quantification. 
4. Serum Fractionation 
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As long ago as 1999, Berger et al. used near IR light at 830nm to perform Raman microscopic 
analysis of liquid whole human blood and serum samples to quantify the content of six analytes, 
namely glucose, cholesterol, triglyceride, urea, total protein and albumin [28]. The total 
acquisition time per sample was 5 min and the samples were continuously stirred in a quartz 
cuvette to minimise heating artefacts from high intensity laser. However, no attempts were 
made to fractionate the serum to deplete the HMWF analytes.  
Centrifugal filtration devices have been utilised to improve the sensitivity of quantitative 
analysis by both Raman and IR spectroscopy, by separating the molecules according to their 
molecular weight [68]. The proteins that are highly abundant in serum dominate the spectral 
profile, and by the removal of these proteins (albumin and globulins,) the ability to monitor 
changes in the lower molecular weight fraction (LMWF) is enhanced. Pre-rinsing of the filter 
devices with 0.1M NaOH prior to plasma analysis is essential to avoid glycerine interference 
in the analysis [67]. The optimised washing and rinsing procedure includes spinning 0.5mL 
0.1M NaOH at 14000×g for 30 minutes, followed by three rinses with distilled water by 
spinning 0.5mL distilled water for 30 minutes at 14000×g. Every 30 minute wash and rinse 
must be followed by spinning the device in the inverted position at 1000×g for 2 minutes, to 
remove the residual solution contained in the filter. After washing, 0.5mL sample is transferred 
to the filter and centrifuged at 14000×g for 30 minutes. The solution that flows out from the 
filter is the filtrate, which contains mostly water and molecules smaller than the pore size of 
the chosen filter. The remainder of the sample, known as the concentrate, is collected by placing 
the filter device upside down and spinning for 1000×g for 2 minutes. The resultant concentrate, 
~50µL, contains molecules with molecular weight larger than chosen pore size, and is 
concentrated by a factor of ~10. This indicates the potential for the prediction of other 
biomolecules that exist within the LMWF with this method, and with further research, such 
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techniques could be translated into the clinical environment as a rapid tool for screening and 
monitoring. 
In the study conducted using 247 blood donors by Rohleder et al. [37], a key was that the 
prediction accuracy of glucose and urea were improved by up to a factor of 2 by depletion of 
the HMWF using centrifugal filtration techniques. The processing protocol has been 
extensively explored for both ATR-FTIR and Raman analysis [39, 68] whereby the HMWF 
can be isolated in the unfiltered concentrate, while the LMWF filtrate can be further 
fractionated and/or concentrated. Notably, Bonnier et al. have highlighted the importance of 
appropriate rinsing of the filters to avoid contamination of the filtrate [67]. In the study of 
Rohleder et al. [37], Raman spectroscopy was used for quantitative analysis of serum and 
serum ultrafiltrate with an accuracy, within the range of clinical interest [37], by using 785nm 
laser as the excitation wavelength and a quartz cuvette to hold the sample. In this measurement 
setup, a minimum of 200 µL sample was required. 10kDa centrifugal filters were used to 
deplete the HMWF from the serum and the spectra of glucose, urea and uric acid were recorded 
from the serum as well as the ultrafiltrate. 
Parachalil et al. further demonstrated the suitability of Raman spectroscopy as a bioanalytical 
tool, when coupled with ultra-filtration and multivariate analysis, to detect imbalances in both 
HMWF (total protein content, γ globulins and albumin) and LMWF (urea and glucose) of the 
same samples of human patient serum, in the native liquid form [69]. Using a validated Partial 
Least Squares Regression (PLSR) method, the γ globulin and total protein analysis models, 
based on unfiltered patient serum, produced R2 values of 0.88 and 0.82, and Root Mean Square 
Error of Crossvalidation (RMSECV) of 126 mg/dL and 115 mg/dL, respectively. Post 
fractionation of the patient serum samples by ultra-filtration using 100 kDa and 50 kDa filters, 
a similar analysis produced an R2 value of 0.91 and RMSECV of 90 mg/dL for albumin, which 
is comparable to the values previously reported for a model of aqueous solutions of albumin 
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over a similar concentration range. In the case of urea, R2 and RMSECV values of 0.90 and 
70.40 mg/dL for the range of aqueous solutions of varying concentrations were achieved, and 
0.92 and 1.73 mg/dL, for the low molecular weight (<10 kDa) filtrate of patient samples, when 
the full spectral range of 400-1800 cm-1 was employed. Reducing the spectral range of the 
analysis to 800 cm-1 to 1030 cm-1 considerably improved the prediction accuracy and 
sensitivity, resulting in an R2 value of 0.97 and RMSECV of 1.14 mg/dL. In the case of glucose, 
a reduced spectral range from 1030 cm-1 to 1400 cm-1 was chosen to avoid interference from 
urea, resulting in an R2 value of 0.84 and RMSECV value of 1.84 mg/dL in the filtrate from 
the same patient samples. Although both the proof-of-concept studies have been carried out on 
rather small populations (25 patient samples), they demonstrate that the method has potential 
for clinical implementation for early disease diagnostics from bodily fluids. In this work, 
ultrafiltration in conjunction with chemometric methods were used to overcome three 
problems: first, eliminating the interference from water and β-carotene; second, extracting the 
Raman signals from LMWF analytes; and third, solving the problems associated with multiple 
analyte variations in the serum. The sample preprocessing enables a fractionation and 
concentration of the different molecular weight fractions of the serum, enabling their analysis 
and quantification without the need for additional enhancement techniques. It has been 
demonstrated that, using Ag or Au colloids, intense and repeatable spectra are only obtained if 
the high molecular weight protein fraction is filtered out from the serum [70]. Enhanced signals 
of the low molecular weight fraction can then be obtained, although the process of addition of 
colloids would add to the workflow in terms of time and cost. 
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5. Data preprocessing  
Data preprocessing, such as spikes removal, baseline correction, smoothing etc., aims to 
remove any perturbations to the spectra due to any distortions to the spectra which might arise 
during the measurement process (scattering, electronic noise). This pretreatment of data is 
critical to accessing the desired information without losing crucial information. The 
fundamental concepts and basic theory of most used chemometric tools in the pharmaceutical 
industry for pre-processing, processing and post-processing of the generated data have been 
detailed in the review article by Sacre et. al [71]. The majority of the commercial software, e.g. 
Labspec, includes real-time spikes correction, enabling visual inspection of the spectra, and/or 
manual spike removal when very few spikes are present. Some algorithms have been developed 
to perform automated spike removal in the case of a large dataset, for which manual correction 
is not possible [72–76]. The most commonly used smoothing algorithm for de-noising the 
spectra without losing much information is that of Savitzky-Golay [77]. Drifts in the baseline 
occurring due to scattering or fluorescence may be corrected using different approaches such 
as asymmetric least squares [78], mixture models [79], polynomial filter [80, 81] and the rubber 
band method [82]. In the study conducted by Medippally et. al., rubber band baseline 
correction, Savitzky–Golay smoothing algorithm  and vector-normalisation was performed on 
the raw Raman spectra of liquid plasma prior to post processing, in R based statistical software 
[50]. In studies aimed at early diagnosis of oral cancer using Raman spectroscopy by Sahu et. 
al.[83] and differentiation Meningioma by Mehta et. al.,[84], raw liquid serum spectra were 
baseline corrected using a fifth order polynomial function, smoothed using Savitzky-Golay 
algorithm and vector normalised in Matlab based statistical software. Fifth order polynomial 
background subtraction from the raw serum spectra and normalisation was also implemented 
in Matlab by Rohdeler et. al. [36] in their study to compare mid-IR and Raman spectroscopy 
in quantitative analysis of serum. Two different algorithms were used by the same group to 
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perform pre-processing of spectra of serum spectra of ultrafiltrate [37]. Spectra originating 
from ultrafiltrate were scaled to the area under the water Raman band at 1640 cm2 after 
determining the area by a Gaussian fit with linearly decreasing background from 1550 to 1770 
cm2. In the case of serum, spectra were scaled to the maximum intensity and a fifth order 
polynomial background was subtracted. In their study to detect alterations in glucose and lipid 
components in the serum using near-IR Raman spectroscopy, Borges et. al.[85] fitted a 
seventh-order polynomial function over the 400-1800 cm–1 region and subtracted from the raw 
serum spectrum to remove the unwanted background, providing an effective baseline 
correction, and spectra were normalised by the area under the curve prior to data analysis. Least 
squares fitting was used by Berger et al. to remove the background mathematically by 
subtraction of a sloped straight line from each serum spectrum without affecting the shape of 
the Raman peaks [86]. Jenkins et. al. subjected the raw Raman spectra of serum to wavenumber 
standardisation, background subtraction using a rolling circle filter algorithm and 
normalisation to the peak at 1004 cm−1 [29]. The phenyl alanine peak was chosen for 
normalisation as it is the sharpest and most intense peak within the serum spectra and it is 
observed that normalisation to this peak produced better diagnostic discriminatory results when 
compared to other normalisation methods such as vector normalisation. 
Although the accepted dogma is that the contribution of water to Raman spectra is significantly 
less than to mid-IR spectra, water still has a significant contribution to the Raman signatures 
in the fingerprint region of bodily fluids, due to the OH stretching vibration at 1640cm-1. 
Analysis of the ultracentrifugation concentrate reduced the relative contribution of the water 
signal [68] but further efforts to remove it by data preprocessing have been explored, to increase 
the relative contribution of the analyte. Kerr et al., [87] have compared a number of commonly 
employed data pre-processing techniques, and, especially in the case where the background 
contains a known interferent, such as substrate or background, demonstrate the benefits of the 
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adapted EMSC model, which also contains a polynomial with linear and higher order 
components.  Parachalil et al. adopted an adapted method of Extended Multiplicative Signal 
Correction (EMSC) [87] to subtract the known spectrum of water from their spectra, initially 
for the analysis of the HMWF in simulated plasma mixtures [44], and subsequently the 
measurement protocol was used to quantitatively monitor diagnostically relevant changes of 
glucose in liquid serum samples (spiked serum samples and patient samples), and the results 
were compared with similar analysis protocols using infrared spectroscopy of dried samples 
[43]. The analysis protocols to detect the imbalances in glucose using Raman spectroscopy 
were first demonstrated for aqueous solutions and spiked serum samples. As in the case of 
infrared absorption studies [40], centrifugal filtration was utilised to deplete abundant analytes 
and to reveal the spectral features of LMWF analytes, in order to improve spectral sensitivity 
and detection limits. After the depletion of the abundant proteins, the dominant water peak 
from the filtrate collected after centrifugal filtration using 10kDa can be removed by using the 
EMSC algorithm, and PLSR analysis applied to obtain a prediction model relating the glucose 
concentrations and the intensity of glucose features. Note, that the study introduced a water 
normalisation factor into the EMSC protocol, using the fitted co-efficient of the water scaling 
factor, which has the effect of scaling the analyte spectra, assuming a constant water 
contribution to all sample spectra. This step helps to considerably reduce the spectral variability 
of the Raman spectra of glucose recorded from 25 patient samples (Figure 3) [44]. 
The principle of EMSC for subtraction of a specific measureable background spectrum and the 
associated Matlab codes have previously been published by Kerr and Hennelly, 2016 [86], and 
their description is adapted in the following. The raw spectrum, S, consists of Raman spectrum 
of interest, R, a baseline signal, B, and the water signal, W. 
S = R + B + W [86]                                                                                        (1) 
16 
 
The Raman spectrum of interest can be represented by a reference spectrum of the material of 
interest, r, and it can be assumed that R is the product of this reference spectrum and a certain 
scalar weight, Cr, which describes the concentration dependence [88,89] 
R ~ Cr x r          [86]                                                                                        (2) 
Similarly, a spectrum, w, is recorded from water directly in order to represent the spectral 
contribution of water in W, as the product of pure water spectrum and a certain scalar weight. 
W = Cw x w      [86]                                                                                           (3) 
The baseline, B, is now represented by an appropriate order of polynomial (N) as: 
BN = C0 + C1X + C2X
2 +……+ CNXN             [86]                                            (4) 
where N is the order of polynomial and Cm for m = 0  N represents various coefficients of 
polynomial. The EMSC algorithm is used to obtain estimates of the scalar values Cr, Cm and 
Cw. These estimates are obtained from an optimal fit of the various vectors in Equation 5. 
S~ [𝐶𝑟 × 𝑟] + [𝐶𝑤 × 𝑤] + [∑ 𝐶𝑚𝑋
𝑚 ]𝑁𝑚=0         [86]                                          (5) 
The background corrected, concentration dependent analyte spectra, T, can be represented as: 
T =
S−[𝐶𝑤 ×𝑤]−[∑ 𝐶𝑚𝑋𝑚]
𝑁
𝑚=0
𝐶𝑤
    [86]                                                                        (6) 
Note, that division by Cw has the effect of scaling the analyte spectra, assuming a constant 
water contribution to all sample spectra.  
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Figure 3. (A) PCA scatter plot of Raman data of the filtrate obtained after ultrafiltration of 
patient serum without scaling the analyte (glucose) spectra from the previously published study 
by Parachalil et. al [44] and (B) after scaling the analyte spectra to the water content. Figure 
3B displays less scatter when compared to Figure 3A, indicating less variability among the 
spectra 
 
However, although the EMSC algorithm removed the underlying water spectra effectively, 
interference from other LMWF analytes, namely, urea was noticed. Hence, a shorter spectral 
range from 1030cm-1 to 1400cm-1 was chosen for data analysis, as this region does not contain 
signature peaks of urea. Improved Root RMSECV was observed for Raman prediction models, 
whereas slightly higher R2 values were reported for infrared absorption prediction models. 
The adapted EMSC algorithm can also be employed to remove known spectral interferents. In 
several studies of human serum, β-carotene has been observed as a string contributor to the 
spectrum, particularly when using 532nm or lower as source, as the scattering from the 
conjugated antioxidant species are resonantly enhanced [29, 50, 83]. The LMWF species are 
not easily removed by centrifugal separation [69], but their contributions can be effectively 
“digitally” removed using the adapted EMSC protocol. 
6. Data Analysis 
A B
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Data analysis protocols can be differentiated into classification protocols, largely employed for 
diagnostic purposes, and regression protocols, predominantly used for quantitation of identified 
analytes. The latter have been explored for both imbalances in intrinsic blood constituents, as 
well as for therapeutic drug monitoring. 
Depciuch et al. collected Raman and FTIR spectra from dried and liquid serum from depressed 
patients and their analysis indicated that both methods provided equally valid results to 
discriminate the patients with similar accuracies [33]. The light source wavelength was 780 nm 
and the sample volume used was 1.5ml, which could be an impediment for clinical translation. 
Other similar studies conducted by the same group using the same set up on phospholipid-
protein balance in human serum and qualitative, quantitative changes in phospholipids and 
proteins in animal depression models. The role of zinc deficiency induced phospholipid-protein 
imbalance in serum of the animal models suggest that both IR and Raman spectroscopic 
techniques could be used as effective tools to identify the changes in the blood serum [30–32]. 
To investigate similarities and differences between the serum samples of different types of 
depression in humans, Principal Components Analysis-Linear Discriminant Classification 
(PCA-LDC) was employed in their analysis of Raman and FTIR spectra from dried and liquid 
serum from depressed patients [33]. The results from both FTIR and Raman spectra 
unambiguously demonstrated that the levels of proteins and phospholipids are higher in healthy 
controls than in depressed subjects and that phospholipids affect the structure of proteins. Two 
measurement strategies were compared in order to determine the influence of water on the 
measured spectra; the first method entailed recording the water spectrum as back-ground, and 
subsequently automatically subtracting it from each serum spectrum, while the second method 
entailed recording a spectrum of the air prior to the spectrum of blood serum and subsequently 
the water spectrum was subtracted from the blood serum without air background. Both the 
methods provided identical serum spectra, suggesting that appropriate measurement of the 
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background and the subtraction of water signal had the greatest impact on the reliability of the 
results. 
Jenkins et al. developed a high-throughput (HT) serum Raman spectroscopy platform and 
compared dry and liquid data acquisition of serum samples for liquid biopsy of 30 colorectal 
cancer patients and 30 matched control patients [29]. Using a stainless steel high throughput 
substrate that allows up to 40 samples to be loaded at once, and 785 nm laser as the excitation 
wavelength, the maximum sensitivity and specificity obtained for discrimination of colorectal 
cancer patients were 77% and 81% respectively. In this study, Raman spectra were subjected 
to routine preprocessing such as wavenumber standardisation, background subtraction using a 
rolling circle filter algorithm and normalisation to the peak at 1004 cm−1. Partial least squares 
discriminant analysis (PLS-DA) was used to investigate causes of differences and variances 
within datasets. PLS-DA models were cross validated using k-fold cross validation with 5 
folds. The sample volume required was 200 µL and the total time for the data collection was 
12.5min. In a clinical setting, it would be advantageous to reduce the data collection time in 
order to avoid delay in analysis. When excitation wavelength of 532nm was used on the liquid 
platform, the specificity was found to be low, due to the prominence of carotenoids in the serum 
spectra. No measures were taken to remove the interference of carotenoids from the spectral 
data. The prominence of carotenoids due to resonance Raman was also reported by Sahu et al., 
in an exploratory study for detection of oral cancers [83] and by Mehta et al., in their study 
conducted to differentiate meningioma. Sahu et. al. used 532nm as excitation source  and 
Raman spectra were collected by placing 30µL serum samples on a glass slide and the laser 
was focused through a 50X Nikon objective. The spectra were vector normalised, baseline 
corrected, smoothed and subjected to PCA-LDA followed by cross-validation using leave-one-
out cross-validation (LOOCV). Although this study reported spectral differences between 
DNA, changes in the plasma amino acid profiles and β-carotene levels across the analysed 
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groups, the strong bands of β-carotene could interfere with the detection of other analytes 
increasing the ambiguity in the results obtained. In the study conducted by Mehta et al., 25 
patient samples from healthy and meningioma groups were subjected to PC and PC-LDA 
followed by LOOCV cross validation, yielding classification efficiency of 92% and 80% for 
healthy and meningioma respectively. Passively thawed 30µL serum samples, on a calcium 
fluoride (CaF2) slides were subjected to Raman analysis using 785nm laser excitation source. 
Borges et al.[85], collected blood serum from 44 volunteers to discriminate between altered 
and normal concentrations of glucose, total cholesterol, triglycerides, low density (HDL) and 
high density lipoproteins (LDL). Raman analysis was performed using 830nm excitation 
source for a sample volume of 100µL. The data collected was subjected to PCA yielding a 
classification efficiency of 77% for total cholesterol, 81% for triglycerides, 59% for HDL and 
60% for LDL.  
In terms of quantification of systematically variable analyte concentrations, multivariate PLSR 
analysis is often the method of choice. PLSR is most commonly employed to construct a model 
that can relate variations of the measured spectral responses to a systematic variation of 
concentrations of the target analyte [90–92]. The constructed model can them be employed to 
identify spectral factors which account for the maximum variation in predictors ‘X’ (spectral 
data) versus associated responses ‘Y’ (target values of protein concentration) [91]. The spectral 
data (X matrix) can thus be related to the target concentrations (Y matrix) according to the 
linear relationship Y = XB +E, in which B and E are matrices of regression coefficients and 
residuals, respectively. The PLSR model can be used to predict the outcome of varying 
concentration of analytes based on the spectral data. The model is validated using a rigorous 
cross validation procedure which evaluates its performance in accurately predicting analyte 
concentrations [44]. In the study of Berger et al., PLSR prediction models were built, using 
leave one out cross validation (LOOCV), for each the six analytes after spectral background 
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removal, providing an root mean square error of 26mg/dL, 12mg/dL, 29mg/dL, 3.8mg/dL, 
0.19mg/dL and 0.12mg/dL for glucose, cholesterol, triglyceride, urea, total protein and 
albumin, respectively [28]. A similar approach was employed by Parachalil et al. [43] to 
compare the predictive capacity of Raman microscopy for quantitation of glucose in human 
serum, compared to the similar ATR-FTIR analysis of Bonnier et al. [87] indicating that the 
RMSECV for Raman of 1.84mg/dL is comparable or better than that of 3.1mg/dL for ATR- 
FTIR.  
Having removed the spectral interferents using EMSC, PLSR can independently identify 
spectral correlation associated with target analyte range. Cross-validation of the PLSR model 
is required to evaluate the accuracy, often cited in terms of the Root Mean Square Error of 
Cross Validation (RMSECV) [93]. The number of latent variables used for construction of the 
PLSR model is optimised by establishing the value that is equivalent to the minimum of the 
RMSECV. The R2 value provides an indication of the correlation between the analyte 
concentration and spectral intensity, while the standard deviation (STD) provides an indication 
of the variation between each spectrum calculated from the same sample. Commonly, a 
multiple fold cross validation approach is employed to validate the robustness of the method. 
Typically, the set of observations is randomly divided into approximately equal size, e.g. 50% 
of the spectral data randomly selected as test set, while the remaining 50% is used as the 
training set [101]. The cross-validation process is then repeated multiple times (the folds), such 
that all observations are used for both training and testing, and each observation is used for 
testing exactly once. The results from the folds can then be averaged to produce a single 
estimation. The Root Mean Square Error of Cross Validation (RMSECV) is calculated from 
the multiple iterations to measure the performance of the model for the unknown cases within 
the calibration set.  
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In order to advance the studies of Berger et al., [86] and Rohleder et al.,[36, 37] using the 
improved inverted microscopy modality, Parachalil et al.[69] also used the EMSC correction, 
ultrafiltration protocols and PLSR analysis to construct models for the quantitation of the whole 
serum (total protein, γ globulin), serum concentrate (albumin) and serum filtrate (urea and 
glucose) of patient samples, resulting in higher accuracy and sensitivity of analysis. The 
strategy demonstrated in this study enables the simultaneous estimation of total protein level 
and detection of imbalance in γ globulin concentration accurately from whole serum, without 
the use of any reagents and without destroying the sample being studied. The proposed method 
has many advantageous over the routinely used biuret method, Turbidimetric Immunoassay 
(TIA) and Radial Immunodiffusion (RID), as the required sample volume can be as low as 
10μL, it is rapid and non-destructive to the medium being studied, whereas the conventional 
methods are considered impractical due to the requirement of large sample volume and 
laborious sample processing steps [94–96]. Moreover, the linearity reported for a comparative 
study of RID and TIA is 0.59 [97], substantially lower than the R2 calculated by Parachalil et 
al. [44]. Using filtration, the albumin was isolated from patient serum and the prediction model 
had a prediction accuracy significantly superior to that reported for the Bromoscerol Green 
method (2.2 g/dL), used to determine albumin concentrations from cirrhotic patients [98]. It 
has previously been reported that selecting the spectral region from 1030 cm-1 to 1400 cm-1 
improved the sensitivity and specificity for the prediction model of glucose from patient 
samples over the concentration range 52.5-434.2 mg/dL, and the technique was demonstrated 
to be at least as accurate as ATR-FTIR of similar patient samples [69], measured in the dried 
state and closer to the accuracy of colorimetric methods, 1.4 mg/dL urea [99] and 2 mg/dL 
glucose [100]. Similarly, higher prediction accuracy (RMSECV=1.14 mg/dL) was attained 
when PLSR analysis was performed on a reduced range for urea from patient samples over the 
concentration range 2.52-78.99 mg/dL, compared to the full range (RMSECV=1.73 mg/dL). 
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This standardised, optimised methodology was also applied to determine the Limit of Detection 
(LOD) and Limit of Quantification (LOQ) for therapeutic drug monitoring (TDM) in human 
serum, using the examples of Busulfan, a cell cycle non-specific alkylating antineoplastic 
agent, and, Methotrexate, a chemotherapeutic agent and immune system suppressant [101]. 
Ultrafiltration of the spiked human pooled serum with 10kDa centrifugal filter efficiently 
recovered the drug in the filtrate prior to performing Raman analysis. The drug concentration 
ranges were chosen to encompass the recommended therapeutic ranges and toxic levels in 
patients. Finally, prediction models were built by using PLSR and LOD and LOQ were 
calculated directly from the linear prediction models. The LOD calculated for Busulfan is 
0.0002 ± 0.0001 mg/mL, 30-40 times lower than the level of toxicity, enabling the application 
of this method in target dose adjustment of Busulfan for patients undergoing, for example, bone 
marrow transplantation. The LOD and LOQ calculated for Methotrexate are 7.8 ± 5 µM and 
26 ±5 µM, respectively, potentially enabling high dose monitoring. Although SERS gives 
promising results in detecting drugs at low concentrations in biological matrices [16, 102], 
qualitative variations within the SERS substrate, and the interference of other biomolecules 
with the SERS spectra, makes quantification in real samples a challenging task [103]. The 
simpler approach, adopted here, of Raman spectroscopy coupled with concentration of the high 
and low molecular weight serum fractions using commercially available centrifugal filter 
devices and multivariate analysis technique ensures that the information in the fractions is 
effectively preserved, while enabling easy detection of the analyte concentration with higher 
accuracy that in the unprocessed sample. Better analysis of serum using Raman spectroscopy 
was observed when the sample was analysed in the inverted geometry using the water 
immersion objective with a 532nm laser as source with Lab-Tek plate as substrate [44]. A drop 
of water is used to minimise the differences in the refractive indexes between sample, objective 
and the substrate. However, the water drop does not contribute to the data collected, as it is 
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outside the focus of the beam. The promising results from the systematic studies conducted by 
Parachalil et al.[69] using this analytical set up combined with chemometric techniques such 
as EMSC to measure concentrations of HMWF, LMWF and drugs in human serum strongly 
indicates a highly significant correlation between predicted and reference concentrations. 
These results suggest that Raman can on its own can detect and quantify concentrations close 
to 1% without the aid of any enhancement method [37]. 
Considering the more general applications of the technique to a broader range of drugs or 
analytes, it is notable that both the LOD and LOQ for a given set up are determined by the STD 
of the measurement of the control (serum or filtered serum), and the Raman scattering 
efficiency of the analyte. To further illustrate this point, the LOD of vitamin B12, cholesterol, 
urea and glucose from liquid samples for this measurement protocol were also determined 
using the method previously reported by Parachalil et al. [101] (Table 1). Figure 4 displays a 
plot of LOD versus the maximum intensity per unit acquisition time, per unit concentration. 
An approximately linear, inverse relationship can be seen, which simply emphasises the maxim 
that the stronger the Raman signal of the analyte, the easier it is to detect. The correlation also 
implies, however, that a simple measurement of the analyte in aqueous solution could be 
employed to predict the LOD, and therefore the suitability of the technique for the therapeutic 
monitoring application. 
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Table 1: LOD of glucose [44], busulfan [101], methotrexate [101], cholesterol, urea [69] and 
vitamin B12 calculated from the PLSR prediction plot of these analytes, compared to the 
maximum Raman intensity of maximum peak per unit acquisition time, per unit 
concentration 
 
Analyte Intensity 
(arb. 
units) 
LOD(mM) 
Glucose 1000 0.0006±0.0005 
Busulfan 19704 0.0008±0.0001 
MTX 1600 0.00076±0.0005 
Cholesterol 216718 0.0006±0.0001 
Urea 540000 0.00033±0.00001 
VB12 1266666 0.00014±0.00002 
 
 
Figure 4. LOD of glucose (44), urea (69), busulfan (101), methotrexate (101), cholesterol, and 
vitamin B12 calculated from the PLSR prediction plot of these analytes, compared to the 
‘maximum Raman intensity of maximum peak per unit acquisition time, per unit 
concentration’. The methodology used for calculating LOD was previously published (101) 
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7. Clinical Translation 
Vibrational spectroscopic techniques have attracted a lot of attention as analytical methods of 
choice for analysing biological samples. The promise of the techniques is based on the abilities 
to objectively fingerprint the biochemical profile underlying early onset of disease in cells, 
tissues or bodilyfluids [3, 6, 9]. The techniques have no requirement of specific reagent, and 
the minimal sample preparation means there should be fewer procedural errors and no major 
time delay in providing the results to the patients. In the case of FTIR, considerable progress 
towards using this technique as a routine diagnostic tool for disease diagnosis has been made. 
Recently, ClinSpec Diagnostic, based at the University of Strathclyde’s Technology & 
Innovation Centre, won a £1.2 million investment to further develop a “revolutionary” blood 
test using FTIR which could potentially improve brain cancer survival rates through early 
detection of the disease [104]. Researchers from Monash University have similarly developed 
FTIR based techniques to analyse disease-causing pathogens in human blood [105]. Advances 
in instrumentation have made FTIR an ideal tool of choice for an increasing number of clinical 
application even though the sample drying step is potentially a huge drawback [19, 68, 106].  
Notably, it is demonstrated that the Raman analysis protocol can yield accuracies which are 
comparable with those reported using infrared absorption based measurements of dried serum, 
without the need for additional drying steps. However, there remain challenges to fulfilling the 
requirements for clinical translation. Distortions in the spectra due to the water contributions, 
low detectability of the low molecular weight fraction analytes, lack of standardisation steps 
and financial factors could be the hindrance for clinical translation in the medical and clinical 
environment. Nevertheless, new strategies have been recently developed to address these 
potential limitations, namely the inverted Raman geometry, low cost (Lab-Tek plate) 
substrates, serum fractionation techniques, selective spectral region analysis and sophisticated 
data preprocessing (EMSC) and analysis (PLSR) techniques. These advances have maximised 
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the diagnostic accuracy and are cost-effective solutions that are likely to be adopted in a clinical 
setting.    
Application of the adapted EMSC based algorithm helped to eliminate the contribution from 
water and scattering associated with the HMWF, and linear predictive models were built from 
the PLSR analysis. It is worth noting that PLSR seeks to correlate systematic variations in the 
spectroscopic profiles with the external target variable, in this case protein concentration. As 
such, the method is not inherently specific to any molecular variations, in the case where 
multiple species vary simultaneously over the same range. The accuracy of the proposed 
method is comparable to that of the most commonly used method for detecting albumin from 
biological fluids, the Enzyme Linked Immunosorbent Assay (ELISA) [107, 108], and the most 
commonly used gold-standard method i.e., the Clauss assay for fibrinogen [109]. The proposed 
approach can be expeditiously employed for early detection of pathological disorders 
associated with high or low plasma/serum analytes.  
Bodily fluids are usually collected from a large number of patients in a hospital, potentially 
delaying the performance of the analysis and availability of results, which may in turn delay 
the therapy, and prolong patient anxiety. The accuracy of the conventional test kits that enable 
point-of-care testing can be poor, and they are can be avoided due to high cost [110,111]. The 
enormous advantage of employing this inverted Raman spectral analysis for real-time 
serum/plasma analysis in a clinical setting is that, in the face of emerging diseases, one could 
get an early diagnosis in a cost effective manner before the disease becomes symptomatic 
(Figure 1). Integrated with smaller spectroscopic instrumentation, implementation of such a 
screening/diagnostic tool in developing countries where conventional diagnostics methods are 
scarce and avoided due to high cost, would bring about a dramatic impact on population 
screening.   
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8. Conclusion 
 
The potential advantages of employing Raman spectroscopy of bodily fluids for disease 
diagnosis apart from its high sensitivity and specificity are: low cost, no reagents are required, 
samples can be probed in the native state and rapid results can be obtained. Although there is 
a wealth of information to support the application of Raman analysis for bodily fluids, this 
approach is still considered young and upcoming in the eyes of medical community, thereby 
hindering its clinical translation. The examples summarised in this article attest to the cost 
effective, easy to use, reproducible method of Raman measurement protocol for detecting 
imbalances in serum/plasma proteins and low molecular weight analytes, as well as therapeutic 
drug monitoring. Significantly improved sensitivity of Raman spectroscopic measurements of 
blood samples in liquid form is achievable by means of serum fractionation and the 
implementation of chemometric approaches. In the case of clinical translation, there remain 
challenges to overcome before it can be a reality. Nevertheless, it has been demonstrated that 
options and alternatives are available to overcome these challenges in using Raman 
spectroscopy for liquid sample analysis, leading to a better accuracy and repeatability and thus 
a better sensitivity. Naturally, the next phase includes not only refining this method and 
improving the technical capabilities to match those of the current clinical needs, but also 
technical advances to translate them from research laboratory to clinical practice. In addition, 
to ensure further relevancy of this method, comparison studies between the gold standard of 
current diagnostic methods and the current method in a large multi-centred randomised clinical 
trials are required. Once these factors are taken into account, it is possible to envisage a routine 
platform providing clinical biochemical analysis at minimal cost.  
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